UCB is a privately held company founded in 1928, dedicated to improving the lives of people with severe central nervous system and immunological conditions. With a global presence in nearly 40 countries, UCB focuses on delivering meaningful solutions that extend beyond medicine, aiming to enhance everyday life for patients. The company nurtures a culture of respect and care, collaborating across borders to enable cutting-edge research shaped by patients’ needs.
UCB's mission is driven by the experiences of patients and caregivers, inspiring innovations that create real value in clinical outcomes and daily life. By listening deeply and working with healthcare professionals, partners, and communities, UCB strives to make a lasting impact. The company's ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives.
UCB employs 14,293 people worldwide, fostering a culture of thoughtful intent and collaboration. The company's headquarters are in Belgium, and it operates with a commitment to reflecting the voices of those it serves in all its work.
| Ownership Public Company |
| Parent Company University of California |
B2B professionals should contact UCB for opportunities in delivering innovative solutions for severe central nervous system and immunological conditions. UCB offers potential partnerships and vendor opportunities for those in the healthcare and pharmaceutical industries.
Sales teams selling healthcare solutions, recruiters seeking roles in pharmaceuticals, and partners offering research and development capabilities should reach out to UCB.
Companies that compete with or operate in similar markets to UCB:
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with UCB